haven't we run the Ph 1 & Ph II trials ourselves for Trofinetide on Retts syndrome patients, and haven't we conducted our own Ph II trials of NNZ 2591 for Phelan McDermid syndrome ourselves, and have 3 other trials of 2591 currently in progress? It's only the Ph III trials of trofinetide and the commercialisation of that which we've licenced out to a bigger partner in the USA. What's to stop us gradually bringing that expertise and resources in house and conducting our own Ph III trials in future. I'm looking forward to us growing organically as we gain financial strength from our growing royalty revenue and milestone payments.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-8830
-
- There are more pages in this discussion • 2,519 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.57 |
Change
-0.040(0.26%) |
Mkt cap ! $1.990B |
Open | High | Low | Value | Volume |
$15.83 | $15.87 | $15.20 | $8.124M | 524.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 64 | $15.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.58 | 597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 64 | 15.490 |
2 | 1474 | 15.480 |
1 | 8454 | 15.460 |
1 | 1808 | 15.440 |
2 | 2028 | 15.400 |
Price($) | Vol. | No. |
---|---|---|
15.580 | 597 | 1 |
15.590 | 1867 | 2 |
15.600 | 602 | 2 |
15.610 | 506 | 1 |
15.620 | 1108 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |